Connect
MJA
MJA

Pharmaceutical preparations

Letters

Mis-deca-n identity?

Elizabeth A S Giugni, Rachel S Boddy and Natalie G Limet

Med J Aust 2007; 187 (6): 370

Letters

Management of warfarin in atrial fibrillation

Peter W Ford and Angela Close

Med J Aust 2007; 187 (6): 371

Letters

Management of warfarin in atrial fibrillation

Beata V Bajorek

Med J Aust 2007; 187 (6): 371

Letters

Guidelines for the management of acute coronary syndromes 2006

Mark Little and Chris Johnstone

Med J Aust 2007; 187 (6): 372

Clinical update

Serotonin toxicity: a practical approach to diagnosis and treatment

Geoffrey K Isbister, Nicholas A Buckley and Ian M Whyte

Med J Aust 2007; 187 (6): 361-365 Free

Letters

Guidelines for the management of acute coronary syndromes 2006

Constantine N Aroney and Philip Aylward

Med J Aust 2007; 187 (6): 372

Editorials

The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?

Ken J Harvey, Anthony H Harris and Liliana Bulfone

Med J Aust 2007; 187 (4): 206-207

For debate

Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme

Andrew Searles, Susannah Jefferys, Evan Doran and David A Henry

Med J Aust 2007; 187 (4): 236-239 Free

Viewpoint

Reference pricing for pharmaceuticals: is the Australia–United States Free Trade Agreement affecting Australia’s Pharmaceutical Benefits Scheme?

Thomas A Faunce

Med J Aust 2007; 187 (4): 240-242

Letters

Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease

Beatrice A Golomb and Marcella A Evans

Med J Aust 2007; 187 (4): 253-253

Letters

Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?

David P Horgan

Med J Aust 2007; 187 (3): 198-200

Letters

Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?

Murray J Walters, Alston M Unwin and Sean B Gills

Med J Aust 2007; 187 (3): 198-200

Letters

Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?

Nicholas A Keks, Graham D Burrows, David L Copolov, Richard Newton, Nick Paoletti, Isaac Schweitzer and John W G Tiller

Med J Aust 2007; 187 (3): 198-200

Departments

Ototoxic ear drops with grommet and tympanic membrane perforations: a position statement

Robert J Black, Vince C Cousins, Peter Chapman, Zoran Becvarovski, Harvey L C Coates, Stephen J O’Leary, Christopher F Perry and Brian J Williams

Med J Aust 2007; 187 (1): 62

Letters

Evaluating medicines: let’s use all the evidence

Mira L Harrison-Woolrych

Med J Aust 2007; 186 (12): 662

Letters

Ototoxic ear drops with grommet and tympanic membrane perforations: a position statement

Robert J Black, Vince C Cousins, Peter Chapman, Zoran Becvarovski, Harvey L C Coates, Stephen J O’Leary, Christopher F Perry and Brian J Williams

Med J Aust 2007; 186 (11): 605-606

Correction

Medicines and breastfeeding: information is available on safe use

Lisa H Amir

Med J Aust 2007; 186 (11): 606

Matters arising

MIMS is not a stand-alone resource

Elizabeth A Donohoo

Med J Aust 2007; 186 (9): 484

Matters arising

The National Prescribing Service should lead

Jim R Stockigt

Med J Aust 2007; 186 (9): 484

Matters arising

Call in independent information sources

John S Dowden

Med J Aust 2007; 186 (9): 484

Matters arising

Deficiencies in drug interaction information

Michelle Sweidan and James F Reeve

Med J Aust 2007; 186 (9): 483

Matters arising

Medicines and breastfeeding: information is available on safe use

Lisa H Amir

Med J Aust 2007; 186 (9): 485

Matters arising

Specialist societies can assist

Leon A Bach

Med J Aust 2007; 186 (9): 483

Matters arising

Misleading information for consumers

David Torpy

Med J Aust 2007; 186 (9): 483-484

Viewpoint

Reporting units for therapeutic drug monitoring: a correctable source of potential clinical error

Graham R D Jones

Med J Aust 2007; 186 (8): 420-421 Free